<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychiatr Dis Treat</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychiatr Dis Treat</journal-id>
<journal-id journal-id-type="publisher-id">Neuropsychiatric Disease and Treatment</journal-id>
<journal-title-group>
<journal-title>Neuropsychiatric Disease and Treatment</journal-title>
</journal-title-group>
<issn pub-type="ppub">1176-6328</issn>
<issn pub-type="epub">1178-2021</issn>
<publisher>
<publisher-name>Dove Medical Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26442764</article-id>
<article-id pub-id-type="pmc">4590577</article-id>
<article-id pub-id-type="doi">10.2147/NDT.S70346</article-id>
<article-id pub-id-type="publisher-id">ndt-11-2441</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Toker</surname>
<given-names>Lilach</given-names>
</name>
<xref ref-type="aff" rid="af1-ndt-11-2441">1</xref>
<xref ref-type="corresp" rid="c1-ndt-11-2441"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Agam</surname>
<given-names>Galila</given-names>
</name>
<xref ref-type="aff" rid="af2-ndt-11-2441">2</xref>
<xref ref-type="aff" rid="af3-ndt-11-2441">3</xref>
<xref ref-type="corresp" rid="c2-ndt-11-2441"></xref>
</contrib>
</contrib-group>
<aff id="af1-ndt-11-2441"><label>1</label>Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada</aff>
<aff id="af2-ndt-11-2441"><label>2</label>Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel</aff>
<aff id="af3-ndt-11-2441"><label>3</label>Mental Health Center, Beer-Sheva, Israel</aff>
<author-notes>
<corresp id="c1-ndt-11-2441">Correspondence: Lilach Toker, Department of Psychiatry, University of British Columbia, 177 Michael Smith Laboratories, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada, Email <email>ltoker@mail.ubc.ca</email></corresp>
<corresp id="c2-ndt-11-2441">Galila Agam, Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, P.O Box 4500, Beer-Sheva 84170, Israel, Email <email>galila@bgu.ac.il</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>9</month>
<year>2015</year>
</pub-date>
<volume>11</volume>
<fpage>2441</fpage>
<lpage>2447</lpage>
<permissions>
<copyright-statement>© 2015 Toker and Agam. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License</copyright-statement>
<copyright-year>2015</copyright-year>
<license>
<license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
</license>
</permissions>
<abstract>
<p>Cumulating evidence for the involvement of mitochondrial dysfunction in psychiatric disorders leaves little to no doubt regarding the involvement of this pathology in mood disorders. However, mitochondrial abnormalities are also observed in a wide range of disorders spanning from cancer and diabetes to various neurodegenerative and neurodevelopmental disorders such as Parkinson’s, Alzheimer’s, Huntington’s, autism, and amyotrophic lateral sclerosis. The apparent lack of specificity questions the role of mitochondrial dysfunction in psychiatric disorders, in general, and in mood disorders, in particular. Is mitochondrial dysfunction a general phenomenon, simplistically rendering brain cells to be more vulnerable to a variety of disease-specific perturbations? Or is it an epiphenomenon induced by various disease-specific factors? Or possibly, the severity and the anatomical region of the dysfunction are the ones responsible for the distinct features of the disorders. Whichever of the aforementioned ones, if any, is correct, “mitochondrial dysfunction” became more of a cliché than a therapeutic target. In this review, we summarize current studies supporting the involvement of mitochondrial dysfunction in different psychiatric disorders. We address the question of specificity and causality of the different findings and provide an alternative explanation for some of the aforementioned questions.</p>
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>bipolar disorder</kwd>
<kwd>psychiatric disorders</kwd>
<kwd>schizophrenia</kwd>
<kwd>Stanley Foundation Brain Collection</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec>
<title>Introduction – what does mitochondrial dysfunction stand for?</title>
<p>The term “mitochondrial dysfunction” is used in the literature to represent different features associated with mitochondria. In some cases, the term may merely represent observed transcriptional changes. For example, some studies used this term in relation to altered expression of a few mitochondria-related genes.<xref ref-type="bibr" rid="b1-ndt-11-2441">1</xref>,<xref ref-type="bibr" rid="b2-ndt-11-2441">2</xref> Based on gene enrichment analysis of the downregulated genes, Konradi et al<xref ref-type="bibr" rid="b3-ndt-11-2441">3</xref> reported mitochondrial dysfunction in Bipolar disorder (BP) but not schizophrenia (SCZ) patients. Others did find enrichment of mitochondrial function among downregulated genes in SCZ patients.<xref ref-type="bibr" rid="b4-ndt-11-2441">4</xref>,<xref ref-type="bibr" rid="b5-ndt-11-2441">5</xref> The term is also used when relating to an increased number of mitochondrial DNA (mtDNA) mutations<xref ref-type="bibr" rid="b6-ndt-11-2441">6</xref> and mitochondrial structural abnormalities.<xref ref-type="bibr" rid="b7-ndt-11-2441">7</xref>,<xref ref-type="bibr" rid="b8-ndt-11-2441">8</xref> In several studies, the authors used oxidative phosphorylation byproducts as indicators of mitochondrial function. For example, Gardner et al<xref ref-type="bibr" rid="b9-ndt-11-2441">9</xref> reported altered mitochondrial function in major depression (MD) based on decreased muscle adenosine triphosphate (ATP) in patients. Additional studies commonly cited as an evidence for mitochondrial dysfunction in psychiatry measured metabolites affected by mitochondrial function: eg, increased lactate and taurine levels were found in SCZ<xref ref-type="bibr" rid="b4-ndt-11-2441">4</xref> and BP patients;<xref ref-type="bibr" rid="b10-ndt-11-2441">10</xref>,<xref ref-type="bibr" rid="b11-ndt-11-2441">11</xref> Du et al measured high-energy phosphate-containing metabolites and found increased glycolysis-derived ATP in SCZ patients;<xref ref-type="bibr" rid="b12-ndt-11-2441">12</xref> and Frey et al reported decreased levels of total creatine in BP patients.<xref ref-type="bibr" rid="b13-ndt-11-2441">13</xref> Finally, activity of mitochondrial complexes was directly measured in a subset of the studies.<xref ref-type="bibr" rid="b14-ndt-11-2441">14</xref>–<xref ref-type="bibr" rid="b16-ndt-11-2441">16</xref></p>
<p>While numerous studies use the term “mitochondrial dysfunction” when summarizing their findings, it is important to consider the impact of the reported mitochondria-related abnormality. Altered expression levels of mitochondrial genes/proteins in a whole tissue does not necessarily indicate abnormalities in the organelle’s function. For example, mitochondria are enriched in the synapses of neurons, and are targeted toward axonal and dendritic synapses during synaptic activity.<xref ref-type="bibr" rid="b17-ndt-11-2441">17</xref>,<xref ref-type="bibr" rid="b18-ndt-11-2441">18</xref> Decreased synaptic density of cortical pyramidal cells were reported in postmortem brain of SCZ patients.<xref ref-type="bibr" rid="b19-ndt-11-2441">19</xref>,<xref ref-type="bibr" rid="b20-ndt-11-2441">20</xref> Thus, decreased level of mitochondrial genes/protein as well as mitochondrial mass might be a direct result of decreased synaptic density in these subjects rather than indicate altered mitochondrial function. In addition, some studies indicate alterations in the energetic state of the cell, while others, eg, those reporting altered morphology, might imply affected mitochondrial function that is unrelated to energy production<xref ref-type="bibr" rid="b8-ndt-11-2441">8</xref> (eg, calcium buffering) or that results in cellular damage due to an increased production of toxic compounds. Relating to, classifying, and understanding the specific mitochondria-related findings is crucial for appreciating the impact of these alteration on the pathophysiology of different psychiatric disorders.</p>
</sec>
<sec>
<title>Mitochondrial dysfunction – an etiological factor or an epiphenomenon?</title>
<p>Comorbidity of mitochondrial dysfunction and psychiatric disorders is well established,<xref ref-type="bibr" rid="b21-ndt-11-2441">21</xref>–<xref ref-type="bibr" rid="b24-ndt-11-2441">24</xref> yet the causality between them is not well understood. Existence of common etiological factor does not corroborate with the different phenotypes and the different medication types for these disorders. In this section, we will discuss the findings supporting the role of mitochondria in the development and progression of psychiatric disorders and the possibility of mitochondrial dysfunction being an outcome of the disease.</p>
<p>Mitochondria are the main source for cellular energy obtained through synthesis of ATP in the oxidative phosphorylation process. Energy impairment in psychiatric disorders was reviewed in detail by Rezin et al.<xref ref-type="bibr" rid="b22-ndt-11-2441">22</xref> Beyond energy production, mitochondrial function includes other processes essential for cell function and viability. The most recognized are calcium buffering and homeostasis<xref ref-type="bibr" rid="b25-ndt-11-2441">25</xref>–<xref ref-type="bibr" rid="b27-ndt-11-2441">27</xref> as well as apoptosis.<xref ref-type="bibr" rid="b28-ndt-11-2441">28</xref> Altered cellular calcium levels were reported in BP patients.<xref ref-type="bibr" rid="b29-ndt-11-2441">29</xref>–<xref ref-type="bibr" rid="b31-ndt-11-2441">31</xref></p>
<p>Support for mitochondrial dysfunction exhibiting an etiological role in psychiatric disorders arises from animal studies. A neuron-specific mutation in mitochondrial DNA (mtDNA) polymerase (POLG), altering the proofreading function of the enzyme, modifies mouse behavior in mood disorder-related paradigms such as the circadian rhythm and the startle response.<xref ref-type="bibr" rid="b32-ndt-11-2441">32</xref> Mice harboring this mutation also exhibit altered monoamine levels and turnover in the amygdala and the hippocampus and an enhanced mitochondrial Ca<sup>2+</sup> uptake.<xref ref-type="bibr" rid="b33-ndt-11-2441">33</xref> In our recent study,<xref ref-type="bibr" rid="b34-ndt-11-2441">34</xref> we induced mild mitochondrial dysfunction in mice by chronic treatment with low doses of rotenone, a mitochondrial complex I inhibitor. We found that such treatment affects several behavioral paradigms associated with facets of depression and mania. Interestingly, the rotenone-induced behavioral effects could be counteracted by chronic lithium treatment (the prototype mood stabilizer). Similar results using different inducers of mitochondrial dysfunction and different mood stabilizers have recently been shown by others.<xref ref-type="bibr" rid="b35-ndt-11-2441">35</xref>,<xref ref-type="bibr" rid="b36-ndt-11-2441">36</xref></p>
<p>In the previous paragraph, we discussed evidence for mitochondrial dysfunction being an etiological factor of psychiatric-like behavioral aspects. However, other pieces of evidence suggest that this might not always be the case, proposing that mitochondrial dysfunction might reflect a consequence/epiphenomenon acquired during the course of the disease as discussed in the next section.</p>
<sec>
<title>Mitochondrial dysfunction as an outcome of autophagy impairment</title>
<p>Psychiatric disorders share with neurodegenerative diseases (eg, Parkinson’s, Alzheimer’s, Huntington’s, autism, and amyotrophic lateral sclerosis) both mitochondrial dysfunction<xref ref-type="bibr" rid="b37-ndt-11-2441">37</xref> and impaired autophagy.<xref ref-type="bibr" rid="b38-ndt-11-2441">38</xref>,<xref ref-type="bibr" rid="b39-ndt-11-2441">39</xref> Autophagy is a cellular process required for proper degradation of protein aggregates, damaged subcellular organelles, and pathogens. The classical molecular pathway regulating autophagy is mediated by the mammalian target of rapamicin (mTor).<xref ref-type="bibr" rid="b40-ndt-11-2441">40</xref> However, an mTOR-independent and inositol-depletion-dependent pathway was later discovered.<xref ref-type="bibr" rid="b41-ndt-11-2441">41</xref> Namely, Sarkar et al<xref ref-type="bibr" rid="b41-ndt-11-2441">41</xref> reported that the three mood stabilizers (lithium, valproic acid, and carbamazepine, all known to reduce inositol levels),<xref ref-type="bibr" rid="b42-ndt-11-2441">42</xref> augment autophagy in cell cultures. Zschocke et al<xref ref-type="bibr" rid="b43-ndt-11-2441">43</xref> have shown that tricyclic and selective serotonin reuptake inhibitor antidepressants also enhance autophagy. Correspondingly, antidepressant-like effects were observed in mice treated with the autophagy-inducing compounds, trehalose<xref ref-type="bibr" rid="b44-ndt-11-2441">44</xref> and rapamycin.<xref ref-type="bibr" rid="b45-ndt-11-2441">45</xref> Similarly, treatment with the typical antipsychotic drug, chlorpromazine, was recently reported to enhance mTOR-depended autophagy.<xref ref-type="bibr" rid="b46-ndt-11-2441">46</xref></p>
<p>Recent studies indicate a reciprocal relationship between mitochondria and autophagy.<xref ref-type="bibr" rid="b47-ndt-11-2441">47</xref>–<xref ref-type="bibr" rid="b50-ndt-11-2441">50</xref> Within this context, it has been reported that cells lacking mtDNA or functional oxidative phosphorylation complexes display impaired autophagy<xref ref-type="bibr" rid="b51-ndt-11-2441">51</xref> and Suzuki et al reported that in yeast, autophagy is required to retain mtDNA integrity under nitrogen starvation.<xref ref-type="bibr" rid="b52-ndt-11-2441">52</xref> These studies suggest a causal relationship between altered autophagy and mitochondrial dysfunction, two characteristics of psychiatric and neurodegenerative disorders.</p>
<p>Mitochondria undergo repeated fission–fusion cycles, crucial to ensure mitochondrial integrity. Fission frequently results in unequal daughter organelles, differing in their membrane potential. The dysfunctional daughter mitochondria is degraded by mithophagy, a cargo-mediated type of autophagy specific to mitochondria.<xref ref-type="bibr" rid="b18-ndt-11-2441">18</xref>,<xref ref-type="bibr" rid="b53-ndt-11-2441">53</xref> Impairment of fission–fusion cycles or aberrant autophagy would result in accumulation of damaged mitochondria in the cell, gradually reaching mitochondrial threshold.<xref ref-type="bibr" rid="b53-ndt-11-2441">53</xref>–<xref ref-type="bibr" rid="b55-ndt-11-2441">55</xref> Thus, it is plausible that compromised autophagy or impairment in fission–fusion cycles are causative factors of mitochondrial dysfunction.</p>
</sec>
<sec>
<title>Mitochondrial dysfunction as an outcome of a lifestyle</title>
<p>Exposure to smoking and drugs of abuse (eg, amphetamines, alcohol) is known to induce oxidative stress and/or mitochondrial dysfunction.<xref ref-type="bibr" rid="b56-ndt-11-2441">56</xref>–<xref ref-type="bibr" rid="b61-ndt-11-2441">61</xref> These findings are highly important in view of the high incidence of comorbidity between psychiatric disorders and substance abuse;<xref ref-type="bibr" rid="b60-ndt-11-2441">60</xref>,<xref ref-type="bibr" rid="b62-ndt-11-2441">62</xref>–<xref ref-type="bibr" rid="b64-ndt-11-2441">64</xref> yet it is unclear whether there is a causative relationship between the two. In addition, psychiatric disorders often involve disturbances in eating and sleeping patterns,<xref ref-type="bibr" rid="b65-ndt-11-2441">65</xref>–<xref ref-type="bibr" rid="b67-ndt-11-2441">67</xref> also shown to impair mitochondrial function.<xref ref-type="bibr" rid="b68-ndt-11-2441">68</xref>–<xref ref-type="bibr" rid="b71-ndt-11-2441">71</xref> Thus, it is possible that at least in some cases, mitochondria-related alterations observed in psychiatric patients are an epiphenomenon, related to disease-induced lifestyle and behavior, rather than a primary etiological factor involved in disease initiation and progression.</p>
</sec>
</sec>
<sec>
<title>Psychiatric disorders – specificity of mitochondrial dysfunction</title>
<sec>
<title>Regional specificity</title>
<p>Ben-Shachar et al<xref ref-type="bibr" rid="b2-ndt-11-2441">2</xref> addressed the issue of disease-specificity of mitochondrial complex I abnormalities. Using postmortem brain specimens, the authors compared the expression level of some of the complex I subunits (NDUFV1, NDUFV2, NDUFS1) in four brain regions of MD, BP, and SCZ patients vs healthy subjects. All three complex I subunits studied showed some extent of differential expression in subjects with the different disorders. Interestingly, a different profile of changes characterized the different disorders. In the striatum, decreased expression of the three subunits was observed in SCZ but not in BP or MD patients. Contrarily, in the cerebellum, differential expression was observed in BP and MD but not SCZ patients. Likewise, in the prefrontal cortex, at least one of the subunits exhibited decreased expression in SCZ and MD, but not in BP patients. Intriguingly, the direction of the change of NDUFV1 and NDUFV2 was opposite in the striatum vs the parieto-occipital cortex region, and the expression of NDUFS1 was not altered in the prefrontal cortex in either of the disorders. Although stemming from a small sample size (n=15/group), these results suggest that while mitochondrial dysfunction is a common characteristic of distinct psychiatric disorders, the particular profiles differ in magnitude and temporal occurrence. Curiously, contradicting findings showing upregulation of the three complex I subunits were reported in the blood cells of SCZ patients.<xref ref-type="bibr" rid="b72-ndt-11-2441">72</xref>–<xref ref-type="bibr" rid="b75-ndt-11-2441">75</xref></p>
</sec>
<sec>
<title>Magnitude specificity</title>
<p>It is worth noting that different phenotypes are obtained following treatment with high vs low doses of the complex I inhibitor, rotenone. Administration of high rotenone doses is used to model Parkinson’s disease in mice.<xref ref-type="bibr" rid="b76-ndt-11-2441">76</xref> The mice exhibit an impaired motor function, protein aggregation in the brain, and death of dopaminergic neurons. Contrarily, treatment with low rotenone doses had no effect on motor function or the well-being of mice but affected behavioral paradigms related to manic and depressive symptoms.<xref ref-type="bibr" rid="b34-ndt-11-2441">34</xref></p>
</sec>
</sec>
<sec>
<title>The comorbidity of psychiatric and mitochondrial disorders</title>
<p>The term “mitochondrial disorders” refers to the disorders arising due to alteration in mitochondrial function. Several aspects make mitochondria unique among other subcellular organelles and relate to the characteristics of mitochondrial disorders:
<list list-type="order"><list-item><p>Mitochondria carry their own DNA (mtDNA) which contains 37 genes encoding for 13 proteins, 22 transfer RNAs (tRNAs), and two ribosomal RNAs (rRNAs).<xref ref-type="bibr" rid="b77-ndt-11-2441">77</xref> The majority of the mitochondrial proteins, including most of the subunits of the complexes of oxidative phosphorylation, are encoded by nuclear DNA (nDNA). All 13 proteins encoded by mtDNA belong to oxidative phosphorylation complexes (with the exception of complex II, which is assembled entirely from proteins encoded by nDNA).</p></list-item><list-item><p>Mitochondria are maternally inherited.<xref ref-type="bibr" rid="b77-ndt-11-2441">77</xref> As such, many of the mitochondrial disorders, particularly those induced by mtDNA mutations, are characterized by maternal transmission.<xref ref-type="bibr" rid="b78-ndt-11-2441">78</xref></p></list-item><list-item><p>With some exceptions, each cell contains numerous mitochondria and thousands of copies of mtDNA which may be similar (a condition designated homoplasmy) or different from each other (heteroplasmy).<xref ref-type="bibr" rid="b78-ndt-11-2441">78</xref> Since numerous mitochondria coexist in a single cell, cells are relatively resistant to mtDNA mutations. The latter will result in a pathological phenotype when a mitochondrial threshold is reached.<xref ref-type="bibr" rid="b54-ndt-11-2441">54</xref></p></list-item><list-item><p>mtDNA replication is separate from that of nDNA and is persistent even in nondividing cells.<xref ref-type="bibr" rid="b79-ndt-11-2441">79</xref> The polymerase responsible for mtDNA replication, <italic>POLG</italic>,<xref ref-type="bibr" rid="b77-ndt-11-2441">77</xref> is encoded by nDNA. Mutations in <italic>POLG</italic> affecting its proofreading function result in accumulating mutations and deletions in mtDNA.<xref ref-type="bibr" rid="b32-ndt-11-2441">32</xref> Increased frequency of the common mtDNA4977 deletion was reported in the brains of BP patients in one study,<xref ref-type="bibr" rid="b80-ndt-11-2441">80</xref> but was not replicated by others.<xref ref-type="bibr" rid="b14-ndt-11-2441">14</xref>,<xref ref-type="bibr" rid="b81-ndt-11-2441">81</xref>–<xref ref-type="bibr" rid="b83-ndt-11-2441">83</xref> Interestingly, although not supporting an increase in mtDNA deletions in BP, Kakiuchi et al<xref ref-type="bibr" rid="b81-ndt-11-2441">81</xref> reported significant upregulation of <italic>POLG</italic> in the frontal cortex of BP subjects.</p></list-item></list></p>
<p>Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial disorder characterized by numerous neuromuscular symptoms. CPEO may be induced by a heterozygous mutation in the proofreading segment of <italic>POLG.</italic><sup>32</sup> Several cases of subjects with CPEO and other mitochondrial disorders and comorbid mood disorders have been recorded.<xref ref-type="bibr" rid="b32-ndt-11-2441">32</xref>,<xref ref-type="bibr" rid="b84-ndt-11-2441">84</xref>–<xref ref-type="bibr" rid="b86-ndt-11-2441">86</xref> Similar homozygous (and to a smaller extent heterozygous) mutations cause motor symptoms in mice.<xref ref-type="bibr" rid="b87-ndt-11-2441">87</xref> In addition to motor dysfunction, these mice exhibit age-dependent increase in the number of mtDNA deletions, specifically in brain and muscle,<xref ref-type="bibr" rid="b87-ndt-11-2441">87</xref> providing a potential link between CPEO and psychiatric disorders.</p>
<p>Are psychiatric disorders related to maternal transmission? Involvement of mtDNA mutations in the etiology of psychiatric disorders would have led to maternal transmission. An early study based on 31 pedigrees reported maternal transmission of BP and therefore suggested the involvement of mtDNA in the pathophysiology of the disorder.<xref ref-type="bibr" rid="b88-ndt-11-2441">88</xref> Although maternal transmission of psychiatric disorders was supported in some studies of both BP<xref ref-type="bibr" rid="b89-ndt-11-2441">89</xref> and SCZ,<xref ref-type="bibr" rid="b90-ndt-11-2441">90</xref> these findings were not replicated in a study of BP II patients.<xref ref-type="bibr" rid="b91-ndt-11-2441">91</xref> A paternal transmission mode was suggested by others<xref ref-type="bibr" rid="b92-ndt-11-2441">92</xref>,<xref ref-type="bibr" rid="b93-ndt-11-2441">93</xref> and Kirk et al<xref ref-type="bibr" rid="b93-ndt-11-2441">93</xref> suggested that a negative selection against maternal transmission occurs in BP. The authors sequenced 23 mitochondrial common variants in BP I patients and control subjects (94 subjects/group). While no difference in the frequencies of mitochondrial haplotypes was found between the groups, a higher genetic distance (ie, dissimilarity between the haplotypes) was found among BP I patients. Since mitochondria are maternally inherited, the authors concluded that a mild negative selection against maternal transmission takes place in this disease. The authors hypothesized that the negative selection is a result of slightly decreased fitness of embryos presented with mutated mtDNA, resulting in increased chances for extinction of the lineage.<xref ref-type="bibr" rid="b93-ndt-11-2441">93</xref></p>
</sec>
<sec>
<title>Different studies, similar subjects</title>
<p>An additional point that should be considered when reviewing the literature or performing meta-analysis is the reuse of the same samples across different studies.<xref ref-type="bibr" rid="b94-ndt-11-2441">94</xref> This issue is particularly important in studies involving postmortem brain tissue, due to the rarity of these samples. For example, many of the studies reporting decreased expression of mitochondrial genes in BP, SCZ, and MD used samples from the Stanley Foundation Brain Collection<xref ref-type="bibr" rid="b1-ndt-11-2441">1</xref>,<xref ref-type="bibr" rid="b2-ndt-11-2441">2</xref>,<xref ref-type="bibr" rid="b5-ndt-11-2441">5</xref>,<xref ref-type="bibr" rid="b16-ndt-11-2441">16</xref>,<xref ref-type="bibr" rid="b81-ndt-11-2441">81</xref>–<xref ref-type="bibr" rid="b83-ndt-11-2441">83</xref> or the Harvard Brain Tissue Resource Center.<xref ref-type="bibr" rid="b3-ndt-11-2441">3</xref>,<xref ref-type="bibr" rid="b8-ndt-11-2441">8</xref> Thus, while at first glance downregulation of mitochondrial genes seems to be highly reproducible in numerous studies, in fact, it is an observation made based on repeated analyses of three small cohorts of subjects (the Stanley Foundation Brain Collection is comprised of two collections – the Neuropathology Consortium Collection and the Array Collection, analyzed independently or together in the different studies).</p>
<p>It is bothersome that studies based on the same cohorts find dissimilar lists of differentially expressed genes<xref ref-type="bibr" rid="b94-ndt-11-2441">94</xref> and, in some cases, even contradicting results. For example, samples of the Stanley Foundation Brain Collection studied by Sabunciyan et al<xref ref-type="bibr" rid="b82-ndt-11-2441">82</xref> were also included in Fuke el al’s study<xref ref-type="bibr" rid="b83-ndt-11-2441">83</xref> study; nevertheless, Sabunciyan et al<xref ref-type="bibr" rid="b82-ndt-11-2441">82</xref> found a significantly lower incidence of mtDNA4977 deletion in BP females vs males, while a higher incidence was reported by Fuke et al.<xref ref-type="bibr" rid="b83-ndt-11-2441">83</xref> Similarly, no downregulated mitochondrial genes were found in the Stanley Foundation Brain Collection samples by Iwamoto et al,<xref ref-type="bibr" rid="b95-ndt-11-2441">95</xref> contradicting other studies using the same cohort.<xref ref-type="bibr" rid="b2-ndt-11-2441">2</xref>,<xref ref-type="bibr" rid="b5-ndt-11-2441">5</xref>,<xref ref-type="bibr" rid="b16-ndt-11-2441">16</xref> These discrepancies suggest that mitochondrial abnormalities might be involved in some but not all patients with psychiatric disorders, and an outcome of a study based on a small sample size is strongly dependent on the particular samples included in study.<xref ref-type="bibr" rid="b83-ndt-11-2441">83</xref></p>
</sec>
<sec>
<title>Conclusion</title>
<p>Numerous studies provide evidence for the involvement of mitochondrial dysfunction in psychiatric disorders. However, interpretation of these findings should be done with caution. Reuse of samples in different studies should be considered. If the same subjects are being tested over and over, it is expected that the studies would find similar results. Moreover, at this point, the causal relationship between psychiatric disorders and mitochondrial alterations remains unclear. Recent findings regarding impaired autophagy in psychiatric and neurodegenerative disorders raise the possibility that at least in some cases, mitochondrial dysfunction might be an outcome of impaired autophagy.</p>
<p>Can different psychiatric disorders with distinct symptoms and drug responsiveness result from similar etiological factors? One possibility is that mitochondrial dysfunction induces vulnerability of brain cells (eg, glia and neurons) to other disease-specific factors. It is also possible that impairment of mitochondrial function is region specific, or that cell susceptibility varies among different brain cells eg, dopaminergic neurons in substantia nigra are extremely sensitive to impaired oxidative phosphorylation due to high energy requirement. Alternatively, mitochondrial dysfunction can be an epiphenomenon related to frequent characteristics of psychiatric patients such as smoking, drug abuse, and disturbed eating and sleeping.</p>
<p>Another issue that remains to be clarified is which of the diverse mitochondrial functions is altered in the different psychiatric disorders. Is it energy production, calcium buffering, or increased production of reactive oxygen species? Without understanding the functional impact of “mitochondrial dysfunction” no adequate attempt for targeted therapy at this level can be made.</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Disclosure</bold>
</p>
<p>The authors report no conflicts of interest in this work.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="b1-ndt-11-2441">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LT</given-names>
</name>
</person-group>
<article-title>Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder</article-title>
<source/>J Psychiatry Neurosci
          <year>2006</year>
<volume>31</volume>
<issue>3</issue>
<fpage>189</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="pmid">16699605</pub-id>
</element-citation>
</ref>
<ref id="b2-ndt-11-2441">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben-Shachar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Karry</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression</article-title>
<source/>PLoS One
          <year>2008</year>
<volume>3</volume>
<issue>11</issue>
<fpage>e3676</fpage>
<pub-id pub-id-type="pmid">18989376</pub-id>
</element-citation>
</ref>
<ref id="b3-ndt-11-2441">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konradi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Eaton</surname>
<given-names>M</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Benes</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Heckers</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Molecular evidence for mitochondrial dysfunction in bipolar disorder</article-title>
<source/>Arch Gen Psychiatry
          <year>2004</year>
<volume>61</volume>
<issue>3</issue>
<fpage>300</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="pmid">14993118</pub-id>
</element-citation>
</ref>
<ref id="b4-ndt-11-2441">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prabakaran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Swatton</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>MM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress</article-title>
<source/>Mol Psychiatry
          <year>2004</year>
<volume>9</volume>
<issue>7</issue>
<fpage>684</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="pmid">15098003</pub-id>
</element-citation>
</ref>
<ref id="b5-ndt-11-2441">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altar</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Jurata</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Charles</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts</article-title>
<source/>Biol Psychiatry
          <year>2005</year>
<volume>58</volume>
<issue>2</issue>
<fpage>85</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">16038679</pub-id>
</element-citation>
</ref>
<ref id="b6-ndt-11-2441">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction in bipolar disorder</article-title>
<source/>Bipolar Disord
          <year>2000</year>
<volume>2</volume>
<issue>3 Pt 1</issue>
<fpage>180</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="pmid">11256685</pub-id>
</element-citation>
</ref>
<ref id="b7-ndt-11-2441">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uranova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Orlovskaya</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vikhreva</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Electron microscopy of oligodendroglia in severe mental illness</article-title>
<source/>Brain Res Bull
          <year>2001</year>
<volume>55</volume>
<issue>5</issue>
<fpage>597</fpage>
<lpage>610</lpage>
<pub-id pub-id-type="pmid">11576756</pub-id>
</element-citation>
</ref>
<ref id="b8-ndt-11-2441">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cataldo</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>McPhie</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>NT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abnormalities in mitochondrial structure in cells from patients with bipolar disorder</article-title>
<source/>Am J Pathol
          <year>2010</year>
<volume>177</volume>
<issue>2</issue>
<fpage>575</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="pmid">20566748</pub-id>
</element-citation>
</ref>
<ref id="b9-ndt-11-2441">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boles</surname>
<given-names>RG</given-names>
</name>
</person-group>
<article-title>Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders</article-title>
<source/>Prog Neuropsychopharmacol Biol Psychiatry
          <year>2011</year>
<volume>35</volume>
<issue>3</issue>
<fpage>730</fpage>
<lpage>743</lpage>
<pub-id pub-id-type="pmid">20691744</pub-id>
</element-citation>
</ref>
<ref id="b10-ndt-11-2441">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dager</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Parow</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain metabolic alterations in medication-free patients with bipolar disorder</article-title>
<source/>Arch Gen Psychiatry
          <year>2004</year>
<volume>61</volume>
<issue>5</issue>
<fpage>450</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="pmid">15123489</pub-id>
</element-citation>
</ref>
<ref id="b11-ndt-11-2441">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Regenold</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Phatak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Marano</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Sassan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Conley</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Kling</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis</article-title>
<source/>Biol Psychiatry
          <year>2009</year>
<volume>65</volume>
<issue>6</issue>
<fpage>489</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="pmid">19103439</pub-id>
</element-citation>
</ref>
<ref id="b12-ndt-11-2441">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Thida</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy</article-title>
<source/>JAMA Psychiatry
          <year>2014</year>
<volume>71</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">24196348</pub-id>
</element-citation>
</ref>
<ref id="b13-ndt-11-2441">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frey</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Nery</surname>
<given-names>FG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study</article-title>
<source/>Bipolar Disord
          <year>2007</year>
<volume>9</volume>
<issue>Suppl 1</issue>
<fpage>119</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="pmid">17543030</pub-id>
</element-citation>
</ref>
<ref id="b14-ndt-11-2441">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavelier</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jazin</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics</article-title>
<source/>Genomics
          <year>1995</year>
<volume>29</volume>
<issue>1</issue>
<fpage>217</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="pmid">8530074</pub-id>
</element-citation>
</ref>
<ref id="b15-ndt-11-2441">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maurer</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Zierz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Möller</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia</article-title>
<source/>Schizophr Res
          <year>2001</year>
<volume>48</volume>
<issue>1</issue>
<fpage>125</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="pmid">11278159</pub-id>
</element-citation>
</ref>
<ref id="b16-ndt-11-2441">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andreazza</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LT</given-names>
</name>
</person-group>
<article-title>Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder</article-title>
<source/>Arch Gen Psychiatry
          <year>2010</year>
<volume>67</volume>
<issue>4</issue>
<fpage>360</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="pmid">20368511</pub-id>
</element-citation>
</ref>
<ref id="b17-ndt-11-2441">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Honick</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>IJ</given-names>
</name>
</person-group>
<article-title>Mitochondrial trafficking to synapses in cultured primary cortical neurons</article-title>
<source/>J Neurosci
          <year>2006</year>
<volume>26</volume>
<issue>26</issue>
<fpage>7035</fpage>
<lpage>7045</lpage>
<pub-id pub-id-type="pmid">16807333</pub-id>
</element-citation>
</ref>
<ref id="b18-ndt-11-2441">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>ZH</given-names>
</name>
</person-group>
<article-title>Mitochondrial trafficking and anchoring in neurons: New insight and implications</article-title>
<source/>J Cell Biol
          <year>2014</year>
<volume>204</volume>
<issue>7</issue>
<fpage>1087</fpage>
<lpage>1098</lpage>
<pub-id pub-id-type="pmid">24687278</pub-id>
</element-citation>
</ref>
<ref id="b19-ndt-11-2441">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glantz</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia</article-title>
<source/>Arch Gen Psychiatry
          <year>2000</year>
<volume>57</volume>
<issue>1</issue>
<fpage>65</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">10632234</pub-id>
</element-citation>
</ref>
<ref id="b20-ndt-11-2441">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Broadbelt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Byne</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>LB</given-names>
</name>
</person-group>
<article-title>Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex</article-title>
<source/>Schizophr Res
          <year>2002</year>
<volume>58</volume>
<issue>1</issue>
<fpage>75</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">12363393</pub-id>
</element-citation>
</ref>
<ref id="b21-ndt-11-2441">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jou</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>NY</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction and psychiatric disorders</article-title>
<source/>Chang Gung Med J
          <year>2009</year>
<volume>32</volume>
<issue>4</issue>
<fpage>370</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="pmid">19664343</pub-id>
</element-citation>
</ref>
<ref id="b22-ndt-11-2441">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezin</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Amboni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zugno</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Quevedo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Streck</surname>
<given-names>EL</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction and psychiatric disorders</article-title>
<source/>Neurochem Res
          <year>2009</year>
<volume>34</volume>
<issue>6</issue>
<fpage>1021</fpage>
<lpage>1029</lpage>
<pub-id pub-id-type="pmid">18979198</pub-id>
</element-citation>
</ref>
<ref id="b23-ndt-11-2441">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scaglia</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The role of mitochondrial dysfunction in psychiatric disease</article-title>
<source/>Dev Disabil Res Rev
          <year>2010</year>
<volume>16</volume>
<issue>2</issue>
<fpage>136</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="pmid">20818728</pub-id>
</element-citation>
</ref>
<ref id="b24-ndt-11-2441">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clay</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Sillivan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Konradi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia</article-title>
<source/>Int J Dev Neurosci
          <year>2011</year>
<volume>29</volume>
<issue>3</issue>
<fpage>311</fpage>
<lpage>324</lpage>
<pub-id pub-id-type="pmid">20833242</pub-id>
</element-citation>
</ref>
<ref id="b25-ndt-11-2441">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friel</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Tsien</surname>
<given-names>RW</given-names>
</name>
</person-group>
<article-title>An FCCP-sensitive Ca2+ store in bullfrog sympathetic neurons and its participation in stimulus-evoked changes in [Ca2+]i</article-title>
<source/>J Neurosci
          <year>1994</year>
<volume>14</volume>
<issue>7</issue>
<fpage>4007</fpage>
<lpage>4024</lpage>
<pub-id pub-id-type="pmid">8027759</pub-id>
</element-citation>
</ref>
<ref id="b26-ndt-11-2441">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizzuto</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pinton</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Carrington</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses</article-title>
<source/>Science
          <year>1998</year>
<volume>280</volume>
<issue>5370</issue>
<fpage>1763</fpage>
<lpage>1766</lpage>
<pub-id pub-id-type="pmid">9624056</pub-id>
</element-citation>
</ref>
<ref id="b27-ndt-11-2441">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunter</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Gunter</surname>
<given-names>KK</given-names>
</name>
</person-group>
<article-title>Uptake of calcium by mitochondria: transport and possible function</article-title>
<source/>IUBMB Life
          <year>2001</year>
<volume>52</volume>
<issue>3–5</issue>
<fpage>197</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="pmid">11798033</pub-id>
</element-citation>
</ref>
<ref id="b28-ndt-11-2441">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>The expanding role of mitochondria in apoptosis</article-title>
<source/>Genes Dev
          <year>2001</year>
<volume>15</volume>
<issue>22</issue>
<fpage>2922</fpage>
<lpage>2933</lpage>
<pub-id pub-id-type="pmid">11711427</pub-id>
</element-citation>
</ref>
<ref id="b29-ndt-11-2441">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder</article-title>
<source/>Cell Calcium
          <year>2008</year>
<volume>44</volume>
<issue>1</issue>
<fpage>92</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="pmid">18177933</pub-id>
</element-citation>
</ref>
<ref id="b30-ndt-11-2441">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perova</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Warsh</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder</article-title>
<source/>Int J Neuropsychopharmacol
          <year>2008</year>
<volume>11</volume>
<issue>2</issue>
<fpage>185</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="pmid">17681086</pub-id>
</element-citation>
</ref>
<ref id="b31-ndt-11-2441">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uemura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Corson</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Perova</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Warsh</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder</article-title>
<source/>Bipolar Disord
          <year>2011</year>
<volume>13</volume>
<issue>1</issue>
<fpage>41</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="pmid">21320251</pub-id>
</element-citation>
</ref>
<ref id="b32-ndt-11-2441">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasahara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kubota</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miyauchi</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes</article-title>
<source/>Mol Psychiatry
          <year>2006</year>
<volume>11</volume>
<issue>6</issue>
<fpage>577</fpage>
<lpage>593</lpage>
<fpage>523</fpage>
<pub-id pub-id-type="pmid">16619054</pub-id>
</element-citation>
</ref>
<ref id="b33-ndt-11-2441">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kubota</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kasahara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ishiwata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miyauchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Abnormal Ca2+ dynamics in transgenic mice with neuron-specific mitochondrial DNA defects</article-title>
<source/>J Neurosci
          <year>2006</year>
<volume>26</volume>
<issue>47</issue>
<fpage>12314</fpage>
<lpage>12324</lpage>
<pub-id pub-id-type="pmid">17122057</pub-id>
</element-citation>
</ref>
<ref id="b34-ndt-11-2441">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toker</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bersudsky</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Plaschkes</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inositol-related gene knockouts mimic lithium’s effect on mitochondrial function</article-title>
<source/>Neuropsychopharmacology
          <year>2014</year>
<volume>39</volume>
<issue>2</issue>
<fpage>319</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="pmid">23924600</pub-id>
</element-citation>
</ref>
<ref id="b35-ndt-11-2441">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezin</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Furlanetto</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Scaini</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania</article-title>
<source/>Mol Neurobiol
          <year>2014</year>
<volume>49</volume>
<issue>2</issue>
<fpage>877</fpage>
<lpage>892</lpage>
<pub-id pub-id-type="pmid">24126971</pub-id>
</element-citation>
</ref>
<ref id="b36-ndt-11-2441">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Streck</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Scaini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jeremias</surname>
<given-names>GC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of Mood Stabilizers on Brain Energy Metabolism in Mice Submitted to an Animal Model of Mania Induced by Paradoxical Sleep Deprivation</article-title>
<source/>Neurochem Res
          <year>2015</year>
<volume>40</volume>
<issue>6</issue>
<fpage>1144</fpage>
<lpage>1152</lpage>
<pub-id pub-id-type="pmid">25894682</pub-id>
</element-citation>
</ref>
<ref id="b37-ndt-11-2441">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Abnormal mitochondrial dynamics and neurodegenerative diseases</article-title>
<source/>Biochim Biophys Acta
          <year>2010</year>
<volume>1802</volume>
<issue>1</issue>
<fpage>135</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="pmid">19799998</pub-id>
</element-citation>
</ref>
<ref id="b38-ndt-11-2441">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fornai</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Longone</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ferrucci</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium</article-title>
<source/>Autophagy
          <year>2008</year>
<volume>4</volume>
<issue>4</issue>
<fpage>527</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="pmid">18367867</pub-id>
</element-citation>
</ref>
<ref id="b39-ndt-11-2441">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cuervo</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Autophagy gone awry in neurodegenerative diseases</article-title>
<source/>Nat Neurosci
          <year>2010</year>
<volume>13</volume>
<issue>7</issue>
<fpage>805</fpage>
<lpage>811</lpage>
<pub-id pub-id-type="pmid">20581817</pub-id>
</element-citation>
</ref>
<ref id="b40-ndt-11-2441">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blommaart</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Luiken</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Blommaart</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>van Woerkom</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Meijer</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes</article-title>
<source/>J Biol Chem
          <year>1995</year>
<volume>270</volume>
<issue>5</issue>
<fpage>2320</fpage>
<lpage>2326</lpage>
<pub-id pub-id-type="pmid">7836465</pub-id>
</element-citation>
</ref>
<ref id="b41-ndt-11-2441">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Floto</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lithium induces autophagy by inhibiting inositol monophosphatase</article-title>
<source/>J Cell Biol
          <year>2005</year>
<volume>170</volume>
<fpage>1101</fpage>
<lpage>1111</lpage>
<pub-id pub-id-type="pmid">16186256</pub-id>
</element-citation>
</ref>
<ref id="b42-ndt-11-2441">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mudge</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Harwood</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>A common mechanism of action for three mood-stabilizing drugs</article-title>
<source/>Nature
          <year>2002</year>
<volume>417</volume>
<issue>6886</issue>
<fpage>292</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="pmid">12015604</pub-id>
</element-citation>
</ref>
<ref id="b43-ndt-11-2441">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zschocke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zimmermann</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Berning</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ganal</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Holsboer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rein</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons – dissociation from cholesterol homeostasis</article-title>
<source/>Neuropsychopharmacology
          <year>2011</year>
<volume>36</volume>
<issue>8</issue>
<fpage>1754</fpage>
<lpage>1768</lpage>
<pub-id pub-id-type="pmid">21508931</pub-id>
</element-citation>
</ref>
<ref id="b44-ndt-11-2441">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kara</surname>
<given-names>NZ</given-names>
</name>
<name>
<surname>Toker</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Agam</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Belmaker</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Einat</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Trehalose induced antidepressant-like effects and autophagy enhancement in mice</article-title>
<source/>Psychopharmacology (Berl)
          <year>2013</year>
<volume>229</volume>
<issue>2</issue>
<fpage>367</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="pmid">23644913</pub-id>
</element-citation>
</ref>
<ref id="b45-ndt-11-2441">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cleary</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Linde</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hiscock</surname>
<given-names>KM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders</article-title>
<source/>Brain Res Bull
          <year>2008</year>
<volume>76</volume>
<issue>5</issue>
<fpage>469</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="pmid">18534253</pub-id>
</element-citation>
</ref>
<ref id="b46-ndt-11-2441">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>YK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells</article-title>
<source/>Carcinogenesis
          <year>2013</year>
<volume>34</volume>
<issue>9</issue>
<fpage>2080</fpage>
<lpage>2089</lpage>
<pub-id pub-id-type="pmid">23689352</pub-id>
</element-citation>
</ref>
<ref id="b47-ndt-11-2441">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elmore</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Grissom</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Lemasters</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>The mitochondrial permeability transition initiates autophagy in rat hepatocytes</article-title>
<source/>FASEB J
          <year>2001</year>
<volume>15</volume>
<issue>12</issue>
<fpage>2286</fpage>
<lpage>2287</lpage>
<pub-id pub-id-type="pmid">11511528</pub-id>
</element-citation>
</ref>
<ref id="b48-ndt-11-2441">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells</article-title>
<source/>Toxicol Sci
          <year>2009</year>
<volume>110</volume>
<issue>2</issue>
<fpage>376</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="pmid">19451193</pub-id>
</element-citation>
</ref>
<ref id="b49-ndt-11-2441">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hailey</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Rambold</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Satpute-Krishnan</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondria supply membranes for autophagosome biogenesis during starvation</article-title>
<source/>Cell
          <year>2010</year>
<volume>141</volume>
<issue>4</issue>
<fpage>656</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="pmid">20478256</pub-id>
</element-citation>
</ref>
<ref id="b50-ndt-11-2441">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okamoto</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Mitochondria breathe for autophagy</article-title>
<source/>EMBO J
          <year>2011</year>
<volume>30</volume>
<issue>11</issue>
<fpage>2095</fpage>
<lpage>2096</lpage>
<pub-id pub-id-type="pmid">21629271</pub-id>
</element-citation>
</ref>
<ref id="b51-ndt-11-2441">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graef</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nunnari</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Mitochondria regulate autophagy by conserved signalling pathways</article-title>
<source/>EMBO J
          <year>2011</year>
<volume>30</volume>
<issue>11</issue>
<fpage>2101</fpage>
<lpage>2114</lpage>
<pub-id pub-id-type="pmid">21468027</pub-id>
</element-citation>
</ref>
<ref id="b52-ndt-11-2441">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Onodera</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ohsumi</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Starvation induced cell death in autophagy-defective yeast mutants is caused by mitochondria dysfunction</article-title>
<source/>PloS One
          <year>2011</year>
<volume>6</volume>
<issue>2</issue>
<fpage>e17412</fpage>
<pub-id pub-id-type="pmid">21364763</pub-id>
</element-citation>
</ref>
<ref id="b53-ndt-11-2441">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Twig</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Shirihai</surname>
<given-names>OS</given-names>
</name>
</person-group>
<article-title>Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view</article-title>
<source/>Biochim Biophys Acta
          <year>2008</year>
<volume>1777</volume>
<issue>9</issue>
<fpage>1092</fpage>
<lpage>1097</lpage>
<pub-id pub-id-type="pmid">18519024</pub-id>
</element-citation>
</ref>
<ref id="b54-ndt-11-2441">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossignol</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Faustin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rocher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Malgat</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mazat</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Letellier</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Mitochondrial threshold effects</article-title>
<source/>Biochem J
          <year>2003</year>
<volume>370</volume>
<issue>Pt 3</issue>
<fpage>751</fpage>
<lpage>762</lpage>
<pub-id pub-id-type="pmid">12467494</pub-id>
</element-citation>
</ref>
<ref id="b55-ndt-11-2441">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knott</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Bossy-Wetzel</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration</article-title>
<source/>Ann N Y Acad Sci
          <year>2008</year>
<volume>1147</volume>
<fpage>283</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="pmid">19076450</pub-id>
</element-citation>
</ref>
<ref id="b56-ndt-11-2441">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miró</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Alonso</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Jarreta</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Casademont</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Urbano-Márquez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cardellach</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes</article-title>
<source/>Carcinogenesis
          <year>1999</year>
<volume>20</volume>
<issue>7</issue>
<fpage>1331</fpage>
<lpage>1336</lpage>
<pub-id pub-id-type="pmid">10383908</pub-id>
</element-citation>
</ref>
<ref id="b57-ndt-11-2441">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunha-Oliveira</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rego</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine</article-title>
<source/>Brain Res
          <year>2006</year>
<volume>1089</volume>
<issue>1</issue>
<fpage>44</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">16638611</pub-id>
</element-citation>
</ref>
<ref id="b58-ndt-11-2441">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Upreti</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Eddington</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>IJ</given-names>
</name>
</person-group>
<article-title>Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage</article-title>
<source/>Curr Pharm Biotechnol
          <year>2010</year>
<volume>11</volume>
<issue>5</issue>
<fpage>434</fpage>
<lpage>443</lpage>
<pub-id pub-id-type="pmid">20420575</pub-id>
</element-citation>
</ref>
<ref id="b59-ndt-11-2441">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Genes and pathways co-associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or nicotine: a review of proteomics analyses</article-title>
<source/>Mol Neurobiol
          <year>2011</year>
<volume>44</volume>
<issue>3</issue>
<fpage>269</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="pmid">21922273</pub-id>
</element-citation>
</ref>
<ref id="b60-ndt-11-2441">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunes</surname>
<given-names>SO</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>HO</given-names>
</name>
<name>
<surname>Prado</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence</article-title>
<source/>Neurosci Biobehav Rev
          <year>2013</year>
<volume>37</volume>
<issue>8</issue>
<fpage>1336</fpage>
<lpage>1345</lpage>
<pub-id pub-id-type="pmid">23660457</pub-id>
</element-citation>
</ref>
<ref id="b61-ndt-11-2441">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Akbar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abdelmegeed</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications</article-title>
<source/>Redox Biol
          <year>2014</year>
<volume>3</volume>
<fpage>109</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="pmid">25465468</pub-id>
</element-citation>
</ref>
<ref id="b62-ndt-11-2441">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Regier</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Farmer</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Rae</surname>
<given-names>DS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study</article-title>
<source/>JAMA
          <year>1990</year>
<volume>264</volume>
<issue>19</issue>
<fpage>2511</fpage>
<lpage>2518</lpage>
<pub-id pub-id-type="pmid">2232018</pub-id>
</element-citation>
</ref>
<ref id="b63-ndt-11-2441">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kessler</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Crum</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Schulenberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Anthony</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey</article-title>
<source/>Arch Gen Psychiatry
          <year>1997</year>
<volume>54</volume>
<issue>4</issue>
<fpage>313</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="pmid">9107147</pub-id>
</element-citation>
</ref>
<ref id="b64-ndt-11-2441">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dierker</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Avenevoli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stolar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Merikangas</surname>
<given-names>KR</given-names>
</name>
</person-group>
<article-title>Smoking and depression: an examination of mechanisms of comorbidity</article-title>
<source/>Am J Psychiatry
          <year>2002</year>
<volume>159</volume>
<issue>6</issue>
<fpage>947</fpage>
<lpage>953</lpage>
<pub-id pub-id-type="pmid">12042182</pub-id>
</element-citation>
</ref>
<ref id="b65-ndt-11-2441">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benca</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Obermeyer</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Thisted</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Gillin</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Sleep and psychiatric disorders. A meta-analysis</article-title>
<source/>Arch Gen Psychiatry
          <year>1992</year>
<volume>49</volume>
<issue>8</issue>
<fpage>651</fpage>
<lpage>668</lpage>
<comment>discussion 669–670</comment>
<pub-id pub-id-type="pmid">1386215</pub-id>
</element-citation>
</ref>
<ref id="b66-ndt-11-2441">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ford</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Kamerow</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?</article-title>
<source/>JAMA
          <year>1989</year>
<volume>262</volume>
<issue>11</issue>
<fpage>1479</fpage>
<lpage>1484</lpage>
<pub-id pub-id-type="pmid">2769898</pub-id>
</element-citation>
</ref>
<ref id="b67-ndt-11-2441">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohayon</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Place of chronic insomnia in the course of depressive and anxiety disorders</article-title>
<source/>J Psychiatr Res
          <year>2003</year>
<volume>37</volume>
<issue>1</issue>
<fpage>9</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">12482465</pub-id>
</element-citation>
</ref>
<ref id="b68-ndt-11-2441">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cirelli</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>How sleep deprivation affects gene expression in the brain: a review of recent findings</article-title>
<source/>J Appl Physiol (1985)
          <year>2002</year>
<volume>92</volume>
<issue>1</issue>
<fpage>394</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="pmid">11744682</pub-id>
</element-citation>
</ref>
<ref id="b69-ndt-11-2441">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andreazza</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Alvarenga</surname>
<given-names>TA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impairment of the mitochondrial electron transport chain due to sleep deprivation in mice</article-title>
<source/>J Psychiatr Res
          <year>2010</year>
<volume>44</volume>
<issue>12</issue>
<fpage>775</fpage>
<lpage>780</lpage>
<pub-id pub-id-type="pmid">20176368</pub-id>
</element-citation>
</ref>
<ref id="b70-ndt-11-2441">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardinali</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Pagano</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Scacchi Bernasconi</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Reynoso</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Scacchi</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Melatonin and mitochondrial dysfunction in the central nervous system</article-title>
<source/>Horm Behav
          <year>2013</year>
<volume>63</volume>
<issue>2</issue>
<fpage>322</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="pmid">22391273</pub-id>
</element-citation>
</ref>
<ref id="b71-ndt-11-2441">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Awad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Constantin-Teodosiu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Macdonald</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Lobo</surname>
<given-names>DN</given-names>
</name>
</person-group>
<article-title>Short-term starvation and mitochondrial dysfunction – a possible mechanism leading to postoperative insulin resistance</article-title>
<source/>Clin Nutr
          <year>2009</year>
<volume>28</volume>
<issue>5</issue>
<fpage>497</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="pmid">19446932</pub-id>
</element-citation>
</ref>
<ref id="b72-ndt-11-2441">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dror</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Karry</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia</article-title>
<source/>Mol Psychiatry
          <year>2002</year>
<volume>7</volume>
<issue>9</issue>
<fpage>995</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="pmid">12399953</pub-id>
</element-citation>
</ref>
<ref id="b73-ndt-11-2441">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taurines</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thome</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Duvigneau</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia</article-title>
<source/>Eur Child Adolesc Psychiatry
          <year>2010</year>
<volume>19</volume>
<issue>5</issue>
<fpage>441</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="pmid">19894076</pub-id>
</element-citation>
</ref>
<ref id="b74-ndt-11-2441">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehler-Wex</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Duvigneau</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Hartl</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Ben-Shachar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Warnke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gerlach</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia?</article-title>
<source/>Eur Child Adolesc Psychiatry
          <year>2006</year>
<volume>15</volume>
<issue>8</issue>
<fpage>504</fpage>
<lpage>507</lpage>
<pub-id pub-id-type="pmid">16788776</pub-id>
</element-citation>
</ref>
<ref id="b75-ndt-11-2441">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akarsu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Torun</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bolu</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features</article-title>
<source/>J Mol Psychiatry
          <year>2014</year>
<volume>2</volume>
<issue>1</issue>
<fpage>6</fpage>
<pub-id pub-id-type="pmid">25713723</pub-id>
</element-citation>
</ref>
<ref id="b76-ndt-11-2441">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cannon</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Tapias</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Honick</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Drolet</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Greenamyre</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>A highly reproducible rotenone model of Parkinson’s disease</article-title>
<source/>Neurobiol Dis
          <year>2009</year>
<volume>34</volume>
<issue>2</issue>
<fpage>279</fpage>
<lpage>290</lpage>
<pub-id pub-id-type="pmid">19385059</pub-id>
</element-citation>
</ref>
<ref id="b77-ndt-11-2441">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taanman</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>The mitochondrial genome: structure, transcription, translation and replication</article-title>
<source/>Biochim Biophys Acta
          <year>1999</year>
<volume>1410</volume>
<issue>2</issue>
<fpage>103</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="pmid">10076021</pub-id>
</element-citation>
</ref>
<ref id="b78-ndt-11-2441">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holt</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Morgan-Hughes</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies</article-title>
<source/>Nature
          <year>1988</year>
<volume>331</volume>
<issue>6158</issue>
<fpage>717</fpage>
<lpage>719</lpage>
<pub-id pub-id-type="pmid">2830540</pub-id>
</element-citation>
</ref>
<ref id="b79-ndt-11-2441">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schapira</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Mitochondrial disease</article-title>
<source/>Lancet
          <year>2006</year>
<volume>368</volume>
<issue>9529</issue>
<fpage>70</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">16815381</pub-id>
</element-citation>
</ref>
<ref id="b80-ndt-11-2441">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stine</surname>
<given-names>OC</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Crowe</surname>
<given-names>RR</given-names>
</name>
</person-group>
<article-title>Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder</article-title>
<source/>Biol Psychiatry
          <year>1997</year>
<volume>42</volume>
<issue>10</issue>
<fpage>871</fpage>
<lpage>875</lpage>
<pub-id pub-id-type="pmid">9359971</pub-id>
</element-citation>
</ref>
<ref id="b81-ndt-11-2441">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kakiuchi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ishiwata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kametani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia</article-title>
<source/>Int J Neuropsychopharmacol
          <year>2005</year>
<volume>8</volume>
<issue>4</issue>
<fpage>515</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="pmid">16202181</pub-id>
</element-citation>
</ref>
<ref id="b82-ndt-11-2441">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabunciyan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kirches</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Krause</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder</article-title>
<source/>J Neural Transm
          <year>2007</year>
<volume>114</volume>
<issue>5</issue>
<fpage>665</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="pmid">17195919</pub-id>
</element-citation>
</ref>
<ref id="b83-ndt-11-2441">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kametani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Quantitative analysis of the 4977-bp common deletion of mitochondrial DNA in postmortem frontal cortex from patients with bipolar disorder and schizophrenia</article-title>
<source/>Neurosci Lett
          <year>2008</year>
<volume>439</volume>
<issue>2</issue>
<fpage>173</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="pmid">18514404</pub-id>
</element-citation>
</ref>
<ref id="b84-ndt-11-2441">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inczedy-Farkas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Remenyi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gal</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Psychiatric symptoms of patients with primary mitochondrial DNA disorders</article-title>
<source/>Behav Brain Funct
          <year>2012</year>
<volume>8</volume>
<fpage>9</fpage>
<pub-id pub-id-type="pmid">22329956</pub-id>
</element-citation>
</ref>
<ref id="b85-ndt-11-2441">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anglin</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Tarnopolsky</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Mazurek</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Rosebush</surname>
<given-names>PI</given-names>
</name>
</person-group>
<article-title>The psychiatric presentation of mitochondrial disorders in adults</article-title>
<source/>J Neuropsychiatry Clin Neurosci
          <year>2012</year>
<volume>24</volume>
<issue>4</issue>
<fpage>394</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="pmid">23224446</pub-id>
</element-citation>
</ref>
<ref id="b86-ndt-11-2441">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rapinesi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Janiri</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kotzalidis</surname>
<given-names>GD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial myopathy and comorbid major depressive disorder: effectiveness of dTMS on gait and mood symptoms</article-title>
<source/>Gen Hosp Psychiatry
          <year>2015</year>
<volume>37</volume>
<issue>3</issue>
<fpage>274.e7</fpage>
<lpage>e9</lpage>
<pub-id pub-id-type="pmid">25799088</pub-id>
</element-citation>
</ref>
<ref id="b87-ndt-11-2441">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kametani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heterozygous Polg mutation causes motor dysfunction due to mtDNA deletions</article-title>
<source/>Ann Clin Transl Neurol
          <year>2014</year>
<volume>1</volume>
<issue>11</issue>
<fpage>909</fpage>
<lpage>920</lpage>
<pub-id pub-id-type="pmid">25540805</pub-id>
</element-citation>
</ref>
<ref id="b88-ndt-11-2441">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMahon</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Stine</surname>
<given-names>OC</given-names>
</name>
<name>
<surname>Meyers</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>DePaulo</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Patterns of maternal transmission in bipolar affective disorder</article-title>
<source/>Am J Hum Genet
          <year>1995</year>
<volume>56</volume>
<issue>6</issue>
<fpage>1277</fpage>
<lpage>1286</lpage>
<pub-id pub-id-type="pmid">7762550</pub-id>
</element-citation>
</ref>
<ref id="b89-ndt-11-2441">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gershon</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Badner</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Detera-Wadleigh</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Ferraro</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Berrettini</surname>
<given-names>WH</given-names>
</name>
</person-group>
<article-title>Maternal inheritance and chromosome 18 allele sharing in unilineal bipolar illness pedigrees</article-title>
<source/>Am J Med Genet
          <year>1996</year>
<volume>67</volume>
<issue>2</issue>
<fpage>202</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="pmid">8723048</pub-id>
</element-citation>
</ref>
<ref id="b90-ndt-11-2441">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shamir</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ovadia</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial DNA HV lineage increases the susceptibility to schizophrenia among Israeli Arabs</article-title>
<source/>Schizophr Res
          <year>2007</year>
<volume>94</volume>
<issue>1–3</issue>
<fpage>354</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="pmid">17566709</pub-id>
</element-citation>
</ref>
<ref id="b91-ndt-11-2441">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Winokur</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Coryell</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Failure to demonstrate parent-of-origin effect in transmission of bipolar II disorder</article-title>
<source/>J Affect Disord
          <year>1998</year>
<volume>50</volume>
<issue>2–3</issue>
<fpage>135</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">9858073</pub-id>
</element-citation>
</ref>
<ref id="b92-ndt-11-2441">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kornberg</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Sadovnick</surname>
<given-names>AD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluating the parent-of-origin effect in bipolar affective disorder. Is a more penetrant subtype transmitted paternally?</article-title>
<source/>J Affect Disord
          <year>2000</year>
<volume>59</volume>
<issue>3</issue>
<fpage>183</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="pmid">10854635</pub-id>
</element-citation>
</ref>
<ref id="b93-ndt-11-2441">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Furlong</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Amos</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial genetic analyses suggest selection against maternal lineages in bipolar affective disorder</article-title>
<source/>Am J Hum Genet
          <year>1999</year>
<volume>65</volume>
<issue>2</issue>
<fpage>508</fpage>
<lpage>518</lpage>
<pub-id pub-id-type="pmid">10417293</pub-id>
</element-citation>
</ref>
<ref id="b94-ndt-11-2441">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elashoff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Higgs</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Yolken</surname>
<given-names>RH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Meta-analysis of 12 genomic studies in bipolar disorder</article-title>
<source/>J Mol Neurosci
          <year>2007</year>
<volume>31</volume>
<issue>3</issue>
<fpage>221</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="pmid">17726228</pub-id>
</element-citation>
</ref>
<ref id="b95-ndt-11-2441">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kakiuchi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bundo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders</article-title>
<source/>Mol Psychiatry
          <year>2004</year>
<volume>9</volume>
<issue>4</issue>
<fpage>406</fpage>
<lpage>416</lpage>
<pub-id pub-id-type="pmid">14743183</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>